Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Inari Medical Inc (NQ: NARI )

46.00 -0.16 (-0.35%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,140,161
Open 45.99
Bid (Size) 41.30 (1)
Ask (Size) 47.00 (1)
Prev. Close 46.16
Today's Range 45.51 - 47.09
52wk Range 36.81 - 71.85
Shares Outstanding 54,313,676
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Harbor Diversified, Altimmune, Sprout Social, and Inari and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
INARI MEDICAL, INC. (NASDAQ: NARI) INVESTOR ALERT: Bernstein Liebhard LLP Announces That A New Case Expanding the Class Period Has Been Filed Against Inari Medical, Inc.
From Bernstein Liebhard LLP
Via GlobeNewswire

Performance

YTD
-30.05%
-30.05%
1 Month
-3.04%
-3.04%
3 Month
+8.52%
+8.52%
6 Month
-28.45%
-28.45%
1 Year
-21.37%
-21.37%

More News

Read More
NARI Investors Have Opportunity to Lead Inari Medical, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sprout Social, Inari, UnitedHealth, and Vestis and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
INARI MEDICAL, INC. (NASDAQ: NARI) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Inari Medical, Inc.
From Bernstein Liebhard LLP
Via GlobeNewswire
NARI Investors Have Opportunity to Lead Inari Medical, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Altimmune, Li Auto, Sprout Social, and Inari and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Rosen Law Firm Urges Inari Medical, Inc. (NARI) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
INARI MEDICAL, INC. (NASDAQ: NARI) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Inari Medical, Inc.
From Bernstein Liebhard LLP
Via GlobeNewswire
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Inari Medical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NARI
Via NewMediaWire
Topics Law Enforcement Lawsuit
Exposures Financial Legal
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Inari Medical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NARI
Via TheNewswire.com
Topics Law Enforcement Lawsuit
Exposures Financial Legal
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Li Auto, Sprout Social, Inari, and UnitedHealth and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Inari Medical, Inc. and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
Kirby McInerney LLP Reminds Inari Medical, Inc. (NARI) Investors of Class Action Filing and Encourages Investors to Contact the Firm
From Kirby McInerney LLP
Via Business Wire
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Inari Medical, Inc. with Losses to Contact the Firm
From Schall Law
Via GlobeNewswire
Inari Medical, Inc. Stockholders: Robbins LLP Urges Investors to Contact the Firm for Information About the NARI Class Action
From Robbins LLP
Via GlobeNewswire
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Inari Medical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NARI
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Inari Medical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NARI
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal
INARI MEDICAL, INC. (NASDAQ: NARI) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Inari Medical, Inc.
From Bernstein Liebhard LLP
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Li Auto, Sprout Social, Inari, and UnitedHealth and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Inari Medical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – NARI
From The Rosen Law Firm PA
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sprout Social, Inari, and Cambium and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
INARI MEDICAL, INC. (NARI) ALERT: Kaplan Fox & Kilsheimer LLP Reminds Investors of Important Deadline in Securities Fraud Class Action
Via NewMediaWire
Topics Fraud Regulatory Compliance
Exposures Legal Regulatory
INARI MEDICAL, INC. (NARI) ALERT: Kaplan Fox & Kilsheimer LLP Reminds Investors of Important Deadline in Securities Fraud Class Action
Via TheNewswire.com
Topics Fraud Regulatory Compliance
Exposures Legal Regulatory
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Inari Medical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – NARI
From The Rosen Law Firm PA
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.